Acro Biomedical (ACBM) Change in Inventory (2017 - 2022)
Acro Biomedical (ACBM) has 6 years of Change in Inventory data on record, last reported at -$296000.0 in Q4 2022.
- For Q4 2022, Change in Inventory fell 166.07% year-over-year to -$296000.0; the TTM value through Sep 2022 reached $744000.0, up 51.84%, while the annual FY2021 figure was $938000.0, 1678.06% up from the prior year.
- Change in Inventory reached -$296000.0 in Q4 2022 per ACBM's latest filing, down from $592000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $980000.0 in Q3 2021 and bottomed at -$560000.0 in Q2 2021.
- Average Change in Inventory over 5 years is $74401.4, with a median of -$8300.0 recorded in 2018.
- The widest YoY moves for Change in Inventory: up 113.24% in 2021, down 219.37% in 2021.
- A 5-year view of Change in Inventory shows it stood at -$86600.0 in 2018, then plummeted by 109.52% to -$181440.0 in 2019, then surged by 358.55% to $469120.0 in 2020, then fell by 4.5% to $448000.0 in 2021, then crashed by 166.07% to -$296000.0 in 2022.
- Per Business Quant database, its latest 3 readings for Change in Inventory were -$296000.0 in Q4 2022, $592000.0 in Q3 2022, and -$296000.0 in Q2 2022.